ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

PHASE3CompletedINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

September 19, 2016

Primary Completion Date

May 24, 2019

Study Completion Date

May 24, 2023

Conditions
Superficial Bladder Cancer
Interventions
BIOLOGICAL

ADSTILADRIN

Trial Locations (34)

10461

Montefiore Medical Center, The Bronx

13210

SUNY Upstate Medical Center, Syracuse

17033

Penn State Milton S. Hershey Medical Center, Hershey

19104

The Hospital of the University of Pennsylvania, Philadelphia

19107

Thomas Jefferson University, Philadelphia

21287

Johns Hopkins Kimmel Cancer Center, Baltimore

22908

University of Virginia Health System, Charlottesville

23462

Urology of Virginia, Virginia Beach

26506

West Virginia University Cancer Institute, Morgantown

27710

Duke University, Durham

29572

Carolina Urologic research Center, Myrtle Beach

29605

Regional Urology, Greenville

30322

Emory University School of Medicine, Atlanta

32610

University of Florida - UF Health Davis Center Pavilion and Shands Med Plaza, Gainesville

33612

H. Lee Moffitt Cancer Center & Research Institute, Tampa

37232

Vanderbilt University Medical Center Dept. of Urologic Surgery, Nashville

48109

University of Michigan, Ann Arbor

49546

Spectrum Health Medical Group, Grand Rapids

53705

University of Wisconsin - Madison, Madison

55455

University of Minnesota, Minneapolis

55905

Mayo Clinic - Rochester, Rochester

60637

University of Chicago - Comprehensive Cancer Research Center, Chicago

63110

Washington University School of Medicine, St Louis

70121

Ochsner Clinic Foundation, New Orleans

73104

The University of Oklahoma Health Sciences Center, Oklahoma City

75390

University of Texas Southwestern Medical Center, Dallas

77030

Baylor College of Medicine, Houston

MD Anderson Cancer Center, Houston

80211

The Urology Center of Colorado, Denver

85234

Banner MD Anderson Cancer Center, Gilbert

90089

Keck School of Medicine at USC Medical Center, Los Angeles

08043

Delaware Valley Urology, LLC, Voorhees Township

27599-7235

University of North Carolina (UNC) - Chapel Hill, Chapel Hill

78229-3900

The Univ. of Texas Health Science Center at San Antonio, San Antonio

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

FKD Therapies Oy

INDUSTRY

collaborator

Society of Urologic Oncology Clinical Trials Consortium

OTHER

lead

Ferring Pharmaceuticals

INDUSTRY